🏗Founder & CEO @Waterdrop_Inc (NYSE:WDH)
🥡Co-founded @Meituan Waimai
🏆@Forbes 30u30 | @WEF YGL
🧠Learning in public: 0→IPO, now AI.
👀Follow me for daily updates!
This bet deserves a bigger argument than my timeline gave it.
Strong case: an industry that's priced risk on paperwork for a century just got a new sensor.
Weak case: rebuilding a room is easy. Making its output accountable is the hard 80%.
I keep going back and forth. Where do you land — insurance, real estate, or something else entirely?
the mind behind imagenet, @drfeifei, and her lab @theworldlabs just dropped atlas — a world model that turns plain video into pixel-perfect 3D space.
most people see a new filmmaking tool.
i run a NYSE-listed insurance & healthcare platform. i see a 100-year-old workflow on a countdown clock ↓
→ claims: assessed without an adjuster on-site
→ underwriting: priced from a walkthrough video
→ telehealth: beyond the flat video call
→ evidence: “show what happened” → “simulate it”
insurance has priced risk on paperwork and photos for a century.
world models turn reality itself into data.
pixels in. premiums out.
the camera just became the most important sensor in my industry — and most of the industry hasn’t noticed yet.
my bet → insurance is the first industry world models quietly rewrite.
what’s yours?
// public log 002
Burgundy on burgundy — these two just look right together. If AI hardware can help us hold onto the moments that matter in our conversations, we get to stay more present. @ComuAI_ nailed it: looks good, works well. That's the AI hardware I actually want.
That new burgundy iPhone deserves a Cherry Red plus-one. 🍒
Comu & Apple. This duo might actually get things done.
Let Comu Action Pro turn “we should” into to-dos.
10 years ago, I started a company with a simple belief: technology should protect more ordinary people.
Today, I returned to @HongKongPolyU as an Adjunct Professor. 🎓
Sharing our journey at the ESG Leadership Talk — and gifting our latest AI hardware @ComuAI_ to Chairman Lam — reminded me why we started.
Same mission, new chapter. Grateful. 🚀
Technology should protect more ordinary people. That has been Waterdrop's mission for 10 years.
This belief brought our Founder & CEO @DrPengSHEN back to @HongKongPolyU — where he was officially appointed as an Adjunct Professor and delivered an ESG Leadership Talk on tech-driven social enterprise. 🎓
From AI-powered insurance to major illness fundraising, Waterdrop has proven that business and social impact can go hand in hand.
In a special moment, he presented a @ComuAI_ to Chairman Lam— our latest AI hardware that bridges the gap between conversation and action.
From startup founder to adjunct professor. The journey continues. 🚀
Meetings: where minutes get taken and hours get lost.
Somewhere between "let's circle back" and "so… who's owning this?", the action items quietly left the room.
Meet @ComuAI_ — a pocket-sized AI workmate that sits on the table, stays in the conversation, and turns talk into to-dos: action items, decisions, next steps, neatly organized before you've even found a pen.
No note-taking gymnastics. No "wait, what did we decide?" Just the meeting — with receipts.
Comu. Your pocket-sized AI workmate.
POV: The meeting ends. Everyone nods. No notes, no owners, no next steps. Tomorrow? Just another ordinary day.
Not this time. @ComuAI_ is on the table.
Pocket-sized. Awake for 70 hours. All ears from 7 meters away. Give it a conversation, and it gives back clear notes, decisions and next steps — even the slides, docs and follow-up emails.
You stay in the conversation. Comu moves the work forward.
@connyb@ComuAI_ Fair enough — it's not trying to be an iPhone. It's trying to be the reason your meetings actually lead somewhere. Beauty contests it may lose. Follow-through? Never. 🙂
@WaterDrop_Inc has become aware of tokens falsely using names such as “water” or claiming affiliation with Waterdrop Inc. / $WDH on X and blockchain platforms. Waterdrop Inc. and its affiliates have never issued, authorized, or participated in any cryptocurrency, token, or digital-asset project.
Some meetings remind you why you started.
9 years after we first met, my friend Piyush Jain brought the @ImpactGuru team to our Beijing office yesterday. I joined online from Shenzhen. Our partners at @WaterDrop_Inc hosted them all morning.
Different countries, same mission: making healthcare and insurance accessible to every family.
AI was the big topic — how it helps us respond faster when a family reaches out for help, and show up better in the hardest moments of their lives.
Grateful for fellow builders on the same journey. Onward.
@Rojvai007@ImpactGuru@WaterDrop_Inc Let's go indeed 🙌 Step by step, family by family. Appreciate you being here — what does global impact look like from where you sit?
@MicNguyenn105@ImpactGuru@WaterDrop_Inc Strange for about two minutes — then surprisingly natural. The screen fades fast when the conversation is real. Have you ever had a reunion like that?
@lylytrann206@ImpactGuru@WaterDrop_Inc Great question. Honestly, it was realizing that two teams, thousands of miles apart, are wrestling with the exact same questions — how to show up faster when a family needs help. That kind of alignment is rare. What mission hits home for you?
@Lianaalane@ImpactGuru@WaterDrop_Inc Well said — shared purpose is what turns time into progress. Lucky to still have good company on the journey. What does purpose look like in your own work?
@AnAnNguyenn98@ImpactGuru@WaterDrop_Inc Thank you! Missions evolve, but when two teams keep pointing at the same North Star for nine years, that's worth treasuring. Here's to the next nine 🌎
@AnAnNguyenn98@ImpactGuru@WaterDrop_Inc It is — and the years made it richer. The best friendships just pick up right where they left off, no matter the distance. Do you have a friendship like that? 🥹
A milestone for AI-driven drug discovery — and for patients waiting on new science.
Insilico Medicine's Rentosertib — an AI-prioritized target, a generative-AI-designed molecule — has dosed its first patient in its Phase III trial (GENESIS-IPF-3) in China for idiopathic pulmonary fibrosis, a progressive disease with no cure today.
Through WingFan, @WaterDrop_Inc 's clinical-trial services arm, our team supports patient recruitment and enrollment for this study.
Rentosertib is investigational and has not been approved by any regulatory authority. But every milestone like this is how new medicine earns its way to patients.